DLD Asset Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

DLD Asset Management’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-300,000	Closed	-$11.3M	–	208
2021 Q1	$11.3M	Buy	+300,000	New	+$7.48M	0.32%	43

DLD Asset Management's FPRX Position: Q2 2021 in Review

DLD Asset Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 300,000 shares — an estimated $11.3M sold.

DLD Asset Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $11.3M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

DLD Asset Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
DLD Asset Management sold 300,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $11.3M.
DLD Asset Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
DLD Asset Management's Five Prime Therapeutics, Inc. position peaked at $11.3M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on DLD Asset Management's 13F filing for Q2 2021, filed 13 Aug 2021.